A highly-skilled team with a proven track record of delivering successful results in every operational area of pharmaceutical commercialization.
We are practice-oriented pharmaceutical professionals with the on-the-job experience and practical expertise to develop and execute a go-to-market strategy to drive results.
Meet our Leadership Team
Jeff Bryant’s more than 25 years in the pharmaceutical industry provides experience in almost every functional aspect of the business.
He began his career as a formulation scientist and later managed the QA and QC functions. From there, Jeff moved into R&D and regulatory affairs management. He advanced into product management and pharmaceutical operations roles before transitioning into commercialization roles in product development and business development.
In 2012, Jeff started his own product development laboratory and consulting firm before purchasing Palmetto Pharmaceuticals three years later. In 2016 Jeff founded Sabal Therapeutics.
Philip Vogt has led start-up pharmaceutical companies to prominent positions in the industry for more than four decades.
He began his career in pharmaceutical operations and later moved into sales, marketing, and executive management positions with ETHEX and Acella, where he helped achieve market share leadership positions and revenue growth. These two successes funded the formation of additional companies for ETHEX and Acella – TherRx Corporation and Avion Pharmaceuticals respectively.
In all, Philip has launched over 100 products in his career. He joined Sabal Therapeutics in 2017.
Alan Sack brings 30+ years of operational and financial management experience to Sabal Therapeutics.
His broad domestic and international background in pharmaceuticals, distribution, wholesale, retail, and the service industries provided the foundation for his extensive professional network of pharmaceutical service providers, industry partners, and developers.
The integration of these partnerships into Sabal’s business model adds breadth and depth to the company’s solutions offering. Alan joined Sabal Therapeutics in 2016.
Of his nearly 25 years of commercial pharmaceutical experience, Wade Harper has spent 20 years in senior level positions as National Sales Director, VP Sales and Marketing, EVP of Commercial Operations, VP Commercial Brands, President, and owner.
He has extensive experience in launching small and medium-sized pharmaceutical companies and has worked with Dura Pharmaceuticals, Elan Pharmaceuticals, Eisai, Cornerstone Therapeutics, Praelia Pharmaceuticals, and Stayma Consulting.
Wade has launched more than 40 pharmaceutical products and medical devices across multiple therapeutic areas.
Gregory Graf joined Palmetto Pharmaceuticals in 2010 as Director of Inside Sales, where he designed and implemented the company’s inside sales strategy.
Greg brings more than 10 years’ experience to his current position and a proven track record of success in sales management and marketing in other industries.
At Sabal Therapeutics, he is responsible for the management of our client companies’ products, as well as facilitating the development and execution of their individual initiatives.